Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Wall Street, though, is clamoring for a rate cut, with an 85% chance of a move in July and a 61% probability of three reductions by year's end.The Fedread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
The flattening of the yield curve is exuding a bad omen for the stock market if history is any guide.Marketsread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Hong Kong Chief Executive Carrie Lam announced at a press conference on Saturday that a contentious bill to allow extraditions to mainland China has been put on hold.China Politicsread more
Stratolaunch, the world's largest airplane, which flew once, is up for sale, sources familiar told CNBC.Investing in Spaceread more
Transparency is key… or is it? With the first-ever non-transparent, actively managed exchange-traded fund receiving approval from the SEC, "ETF Edge" goes straight to the...ETF Edgeread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
A new update to the Apple Watch called watchOS 6 will notify you if the environment you're in is too loud and could damage your hearing.Technologyread more
IQOS isn't for sale in the U.S. yet, but Philip Morris USA is already planning its rollout.
The Food and Drug Administration is reviewing Philip Morris International's proposal to sell IQOS and another to allow it to be marketed as a product that is less riskier than conventional cigarettes. If approved, the Altria unit will have sole distribution rights to market PMI's IQOS in the U.S.
IQOS heats tobacco instead of burning it, which is said to be safer than conventional cigarettes because it prevents combustion and the production of most of the harmful chemicals. Philip Morris International already sells IQOS in key cities in 31 markets outside the U.S.
"IQOS is a unique product, protected by intellectual property, and will provide significant first-mover advantage to Altria with the world's leading heated tobacco product," Altria CEO Marty Barrington said Thursday at the company's investor day.
Approval could come as early as February, and Philip Morris USA is preparing accordingly. It has identified the market it will launch IQOS, as well as those it plans to expand into, Sarah Knakmuhs, Philip Morris USA's vice president of heated tobacco products said in a presentation Thursday.
She didn't disclose the location of IQOS' launch market, though she did say they will be focused in major metropolitan areas. The criteria revolve around the adult smoking population, ideally those who have rejected e-cigarettes, the strength of retail partnerships, as well as the legislative and regulatory environment.
PM USA, which sells Marlboro cigarettes in the U.S., will try to build on the brand's recognition and promote IQOS' Marlboro-branded heat sticks. It will market the device as a way to get similar taste and satisfaction of traditional tobacco products without the smell and ash that offends some.
PM USA plans to open IQOS-focused stores and mobile units at select retail partners' stores and events. The company is still considering multiple formats, though the idea is that consumers can sample the IQOS device and heat sticks with the help of trained salespeople and buy the device or opt for a trial period.
Retailers have already expressed interest in stocking IQOS, Knakmuhs said, but PM USA will still build a sales team to promote the brand. The devices will also be sold online.
"Of course, financial performance will also be important," Knakmuhs said. "We expect to learn a lot about this from our initial markets, including IQOS pricing dynamics, volume and competitive sourcing. As you can imagine, we've done extensive scenario planning to assess potential financial performance across several variables and assumptions."
Shares of Altria fell 1.2 percent on Thursday. They've fallen 5.5 percent this year. The FDA's plan to reduce nicotine in cigarettes spooked investors, even though action could be years away.